Heilongjiang ZBD Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥10.27 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	15.81
Forward PE	9.83
Price to Sales TTM	CN¥3.29
Price to Book MRQ	CN¥1.32
Enterprise to Revenue	4.19
Enterprise to EBITDA	15.03

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	20.96%
Operating Margin	10.07%
Return on Assets TTM	3.51%
Return on Equity TTM	8.18%

Income Statement

Revenue TTM	CN¥3,117,259,008
Revenue per Share TTM	CN¥3.32
Quarterly Revenue Growth	-26.30%
Gross Profit TTM	CN¥1,445,576,704
EBITDA	CN¥914,128,132
Net Income to Common TTM	CN¥653,389,760
Diluted EPS TTM	CN¥0.69
Quarterly Earnings Growth YoY	-96.10%

Balance Sheet

Total Cash MRQ	CN¥966,158,080
Total Cash per Share MRQ	CN¥1.03
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	40.54
Current Ratio MRQ	2.69
Book Value per Share MRQ	CN¥8.26

Cash Flow

Operating Cash Flow TTM	CN¥-338,189,600
Levered Free Cash Flow TTM	CN¥-328,568,192

603567 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	941,140,992
Float Shares	351,411,983
Avg 10 Volume	4,684,827
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	73.48%
% Held by Institutions	5.20%

Stock Price Summary

Beta	0.35
Fifty Two Week Low	CN¥8.89
Fifty Two Week High	CN¥13.63
Fifty Two Week Change	-0.46%
Day 50 MA	CN¥11.65
Day 200 MA	CN¥11.44

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.80
Forward Annual Dividend Yield	7.33%
Trailing Annual Dividend Rate	CN¥0.20
Trailing Annual Dividend Yield	1.83%
Payout Ratio	28.80%
Dividend Date
Ex Dividend Date	2024-07-12
Last Split Factor
Last Split Date	2016-06-13